Blue-Light Endoscope Trial Closed

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 5
Volume 4
Issue 5

RICHMOND, BC, Canada--Xillix Technologies Corp. has closed the North American multicenter clinical trial of its LIFE (lung imaging fluorescence endoscope)-Lung Imaging System that began in April, 1993.

RICHMOND, BC, Canada--Xillix Technologies Corp. has closed theNorth American multicenter clinical trial of its LIFE (lung imagingfluorescence endoscope)-Lung Imaging System that began in April,1993.

The system uses tissue autofluo-rescence to enhance the physician'sability to locate suspicious lung tissue for biopsy. By usingblue rather than conventional white light, the system can pickup subtle differences between precancerous or cancerous tissueand normal tissue, the company said.

Preliminary data showed a relative improvement of 161% in theability to identify suspicious tissue for moderate to severe dysplasiaor worse when the LIFE System was used as an adjunct to whitelight bronchoscopy versus white light bronchoscopy alone.

Related Videos
Caitlin Costello, MD, with the Oncology Brothers
Caitlin Costello, MD, with the Oncology Brothers
Caitlin Costello, MD, with the Oncology Brothers
Caitlin Costello, MD, with the Oncology Brothers
A panel of 4 experts on lung cancer
A panel of 4 experts on lung cancer
Collaboration among nurses, social workers, and others may help in safely administering outpatient bispecific T-cell engager therapy to patients.
Immunotherapy may be an “elegant” method of managing colorectal cancer, says Gregory Charak, MD.
D. Ross Camidge, MD, PhD, spoke about how the approval of alectinib is the beginning of multiple other approvals for patients with ALK-positive NSCLC.